Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Status: Recruiting
Location: See all (5) locations...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:
• Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);
• Subject must be able to understand and sign an approved informed consent form;
• Subject is willing to complete all the required study visits for the duration of the study;
• Other protocol-defined inclusion criteria may apply.
Locations
United States
California
Wolstan & Goldberg Eye Associates
RECRUITING
Torrance
Missouri
Moyes Eye Center
RECRUITING
Kansas City
South Carolina
Carolina Eyecare Physicians LLC
RECRUITING
Mt. Pleasant
Texas
Houston Eye Associates
RECRUITING
Houston
Utah
The Eye Institute of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Alcon Call Center
alcon.medinfo@alcon.com
1-888-451-3937
Time Frame
Start Date: 2025-10-14
Estimated Completion Date: 2026-10
Participants
Target number of participants: 120
Treatments
Experimental: Clareon PanOptix Pro/Pro Toric Trifocal IOL
The clouded lens will be removed by phacoemulsification, after which the PanOptix Pro and/or PanOptix Pro Toric IOLs will be implanted.
Related Therapeutic Areas
Sponsors
Leads: Alcon Research